LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
195,900
-7,600 (-3.73%)
Apr 29, 2026, 10:10 AM KST
75.70%
Market Cap 7.42T
Revenue (ttm) 141.55B
Net Income (ttm) -74.28B
Shares Out 36.44M
EPS (ttm) -2,042.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 98,177
Average Volume 406,438
Open 205,000
Previous Close 203,500
Day's Range 195,000 - 208,500
52-Week Range 94,000 - 225,000
Beta 0.62
RSI 55.57
Earnings Date May 15, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.